Skip to main content

Junliang Xu, PhD

Academic Title:

Assistant Professor

Primary Appointment:

Radiation Oncology

Location:

UMMC/Radiation Oncology GGJ40

Phone (Primary):

410-328-2174

Education and Training

  • University of Science & Technology of China, B.S., Theoretical Physics, 2006
  • Kansas State University, Ph.D., AMO Physics, 2012
  • The Ohio State University, Postdoctoral Researcher, AMO Physics, 2017
  • Fox Chase Cancer Center, Residency, Therapeutical Medical Physics, 2020

Biosketch

Dr. Junliang Xu joined University of Maryland on July 2020 as Assistant Professor in the Department of Radiation Oncology, after the completion of his medical physics residency at Fox Chase Cancer Center in Philadelphia, PA. He is also an associate faculty with University of Maryland Baltimore Graduate School for the medical physics certificate program since 2021. He received a Bachelor of Theoretical Physics at the University of Science & Technology in China.  He completed his Ph.D. in Physics at Kansas State University, followed by his Postdoctoral Fellowship in the Department of Physics at The Ohio State University. His research interests include FLASH therapy, Linac-based SRS, single vocal cord irradiation, dual-energy CT, and radiobiology.

Highlighted Publications

  • Poirier, S. Mossahebi, S. J. Becker, B. Koger, Junliang Xu, N. Lamichhane, P. G. Maxim, & A. Sawant “Radiation shielding and safety implications following linac conversion to an electron FLASH-RT unit” Med. Phys. 48, 5396-5405 (2021)
  • Poirier*, Junliang Xu*, S. Mossahebi, F. Therriault-Proulx, & A. Sawant “Characterization and practical applications of a novel plastic scintillator for online dosimetry for an ultrahigh dose rate (FLASH)” Med. Phys., 1-11 (2022); https://doi.org/10.1002/mp.15671    * These authors contributed equally to the work
  • Cao, D. Kunaprayoon, Junliang Xu, & L. Ren “AI-assisted clinical decision making (CDM) for dose prescription in radiosurgery of brain metastases using three-path three-dimensional CNN” Clin. Transl. Radiat. Oncol. 39, 100565 (2023); https://doi.org/10.1016/j.ctro.2022.100565

Additional Publication Citations

×